Cora Health charges $175/month for semaglutide and $225/month for tirzepatide on recurring plans, with prepaid annual rates dropping to $99 and $135 per month. We compare all four plan tiers, calculate 12-month totals, and show what PlexusDx charges for the same medications.

Willow charges $299/month for compounded semaglutide and $399/month for tirzepatide, with no separate membership fees. We break down what's included, compare like-for-like 12-month costs, and show how route options and dose-flat pricing affect total spend.

PlexusDx and Zealthy both offer compounded semaglutide, but upfront commitment, membership fees, and total costs differ. Here's what the evidence shows as of September 2026.

10Rx charges $299 per quarter for semaglutide and $450 per quarter for tirzepatide, both with B12 and no membership fees. We break down the quarterly prepaid model, compare total 12-month cost against month-to-month alternatives, and explain the prepayment commitment.

AltRx advertises compounded semaglutide from $89/month and tirzepatide from $149/month through September 5, 2026. The promotion includes all services at one price—but the standard refill rate after the sale ends is not disclosed, making total cost uncertain.

Alan Meds advertises compounded semaglutide with conflicting pricing structures: a promotional two-month offer and a first-month-then-refill model. We compare both against PlexusDx's transparent month-to-month and commitment rates.

Pomegranate Health advertises $119/month for compounded semaglutide and $149/month for tirzepatide—no membership fee listed—but dose-tier pricing and upfront charges need checkout confirmation.

Mochi Health charges per-dose medication fees plus membership. Starting doses run $60–$90/month for medication, with a first-month membership rate, but higher doses increase cost and the ongoing membership fee requires checkout confirmation.

IVIM Health advertises $100/month semaglutide and $183.33/month tirzepatide, but both require multi-month prepayment and a separate $75/month membership. We calculate the total 12-month cost for each bundle and compare it to month-to-month and commitment options.

Fifty410 charges $199/month for semaglutide with no membership fee and $399–$549 upfront for three-month tirzepatide tiers. This breakdown shows what you actually pay each month, how billing works, and where the total cost lands over twelve months.

BrightMeds charges $129/month for semaglutide and $149/month for tirzepatide with no membership or lab fees. We break down the full cost structure, compare promotional vs. standard rates, and show where PlexusDx fits.

Lavender Sky Health advertises compounded tirzepatide at a prepaid per-month equivalent rate plus separate consult fees, while Emerge uses dose-tiered monthly billing with no additional charges. We normalize billing structures and calculate 12-month costs to show what you actually pay.

Hims & Hers advertises compounded semaglutide at a monthly rate but requires $1,194 upfront for six months. PlexusDx offers month-to-month billing or lower rates on voluntary commitments—never a prepayment lock.

Zealthy advertises compounded semaglutide at $151/month when billed quarterly and branded GLP-1s from $25/month with insurance. We document what's disclosed, what requires checkout, and where evidence gaps prevent a full cost comparison.

Found offers two pricing models—insurance-supported plans and cash-pay subscriptions—with rates ranging from a 12-month prepaid equivalent of $99/month to $359/month billed monthly. We break down each track's real recurring costs, medication coverage, and what the insurance option actually covers.

AltRx advertises steep promotional discounts on compounded semaglutide and tirzepatide through September 5, 2026, but individual reports allege unexpected billing practices and standard rates are unknown. PlexusDx publishes one flat rate with no promotion cycles or prepayment options.

Peak Wellness charges $249/month for semaglutide and $349/month for tirzepatide on standard ongoing terms. Prepaid six-month plans bring tirzepatide to $232.67/month—lower than some competitors at that commitment level.